Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells

Proceedings of the National Academy of Sciences of the United States of America
Javier A MenendezRuth Lupu

Abstract

Fatty acid synthase (FAS) activity is a potential therapeutic target to treat cancer and obesity. Here, we have identified a molecular link between FAS and HER2 (erbB-2) oncogene, a marker for poor prognosis that is overexpressed in 30% of breast and ovarian cancers. Pharmacological FAS inhibitors cerulenin and C75 were found to suppress p185(HER2) oncoprotein expression and tyrosine-kinase activity in breast and ovarian HER2 overexpressors. Similarly, p185(HER2) expression was dramatically down-regulated when FAS gene expression was silenced by using the highly sequence-specific mechanism of RNA interference (RNAi). Pharmacological and RNAi-mediated silencing of FAS specifically down-regulated HER2 mRNA and, concomitantly, caused a prominent up-regulation of PEA3, a transcriptional repressor of HER2. A cytoplasmic redistribution of p185(HER2) was associated with marked morphological changes of FAS RNAi-transfected cells, whereas chemical inhibitors of FAS promoted a striking nuclear accumulation of p185(HER2). The simultaneous targeting of FAS and HER2 by chemical FAS inhibitors and the humanized antibody directed against p185(HER2) trastuzumab, respectively, was synergistically cytotoxic toward HER2 overexpressors. Similarly,...Continue Reading

Associated Clinical Trials

References

Jan 1, 1975·Methods in Enzymology·R Dils, E M Carey
May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·P CarterH M Shepard
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·F P KuhajdaG R Pasternack
Sep 7, 1989·The New England Journal of Medicine·F P KuhajdaG R Pasternack
Sep 30, 1994·Biochemical and Biophysical Research Communications·Y Xie, M C Hung
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·F P KuhajdaG R Pasternack
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·J V SwinnenG Verhoeven
Mar 15, 2000·Proceedings of the National Academy of Sciences of the United States of America·F P KuhajdaC A Townsend
May 10, 2000·Drugs·A J Matheson, S Noble
Sep 27, 2000·International Journal of Cancer. Journal International Du Cancer·J V SwinnenG Verhoeven
Aug 28, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Baselga, J Albanell
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles L VogelMichael Press
Dec 20, 2002·Cancer·Katherine A McGlynnRobert E Tarone

❮ Previous
Next ❯

Citations

Aug 4, 2009·European Journal of Drug Metabolism and Pharmacokinetics·Da-Hua FuZhi-Min Han
Oct 31, 2012·Apoptosis : an International Journal on Programmed Cell Death·Na Young JeongYoung Hyun Yoo
Dec 7, 2005·Breast Cancer Research and Treatment·James J DignamD Lawrence Wickerham
Sep 13, 2007·Cancer Metastasis Reviews·Yong Q ChenIsabelle M Berquin
Jun 19, 2012·Cancer Metastasis Reviews·Swethajit BiswasKim Bartlett
Feb 25, 2005·Lipids·Subrahmanyam S Chirala, Salih J Wakil
Dec 5, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yu-Chien KaoChien-Feng Li
Jul 6, 2011·Journal of Medicinal Chemistry·Hanley N Abramson
May 9, 2012·Journal of Medicinal Chemistry·Carlos TurradoMaría L López-Rodríguez
Mar 9, 2013·Cell Death & Disease·Y ZhaoM Tan
Sep 30, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Kristin C JensenMatt van de Rijn
Mar 17, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Ann Smith SehdevIe-Ming Shih
Sep 21, 2007·Nature Reviews. Cancer·Javier A Menendez, Ruth Lupu
Jun 19, 2013·Oncogene·X WangD S Conklin
Nov 26, 2010·The Journal of Biological Chemistry·Xiaochao WeiClay F Semenkovich
Jan 10, 2012·Nucleic Acid Therapeutics·Chan Il ChangDong-Ki Lee
Jan 5, 2008·Carcinogenesis·Chien-Chih OuMing-Ching Kao
Aug 9, 2008·Journal of Biochemistry·Yuanyan WeiJianhai Jiang
Nov 3, 2005·Journal of the National Cancer Institute·Javier A MenendezRuth Lupu
Mar 30, 2007·Nucleic Acids Research·Scott E MartinNatasha J Caplen
Jun 17, 2006·Current Opinion in Clinical Nutrition and Metabolic Care·Javier A Menendez, Ruth Lupu
Jun 17, 2006·Current Opinion in Clinical Nutrition and Metabolic Care·Johannes V SwinnenGuido Verhoeven
Feb 1, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J A MenendezR Lupu
Jul 20, 2007·Molecular and Cellular Biology·Josie Ursini-SiegelWilliam J Muller
Aug 30, 2008·Molecular Cancer Therapeutics·James RossSabrina M Ronen
Jan 4, 2005·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·P D Rye, T Stigbrand
Nov 10, 2007·The Journal of Clinical Investigation·David M SelvaGeoffrey L Hammond
Jun 15, 2007·BMC Genomics·Lynn M Knowles, Jeffrey W Smith
Mar 21, 2009·Breast Cancer Research : BCR·Antonis KourtidisDouglas S Conklin
Nov 18, 2010·Breast Cancer Research : BCR·Quanri JinFrancisco J Esteva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis